TickerFacts.

Emergent BioSolutions Inc. (EBS) — Revenue

Annual figures by period end, from SEC filings.

2010-12-31: $286.17M2011-12-31: $273.38M2012-12-31: $281.89M2013-12-31: $312.75M2014-12-31: $450.14M2015-12-31: $522.79M2019-12-31: $1.11B2020-12-31: $1.58B2021-12-31: $1.77B2022-12-31: $1.12B2023-12-31: $1.05B2024-12-31: $1.04B2025-12-31: $742.90M$742.90M
2010-12-31Revenue (USD)2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$742.90M-28.8%2026-02-27From 2025-01-01
2024-12-31$1.04B-0.5%2026-02-27From 2024-01-01
2023-12-31$1.05B-6.1%2026-02-27From 2023-01-01
2022-12-31$1.12B-37.0%2025-03-04From 2022-01-01
2021-12-31$1.77B+12.4%2024-03-08From 2021-01-01
2020-12-31$1.58B+42.6%2023-12-11From 2020-01-01
2019-12-31$1.11B—2022-02-25From 2019-01-01
2015-12-31$522.79M+16.1%2016-02-29From 2015-01-01
2014-12-31$450.14M+43.9%2016-02-29From 2014-01-01
2013-12-31$312.75M+10.9%2016-02-29From 2013-01-01
2012-12-31$281.89M+3.1%2015-03-09From 2012-01-01
2011-12-31$273.38M-4.5%2014-03-10From 2011-01-01
2010-12-31$286.17M—2013-03-08From 2010-01-01